Dr. Claudia Morris, MD
Claim this profileChildren's Healthcare of Atlanta, Emory University
Area of expertise
Sickle Cell Disease
Claudia Morris, MD has run 2 trials for Sickle Cell Disease. Some of their research focus areas include:
Coronavirus
Claudia Morris, MD has run 1 trial for Coronavirus.
Affiliated Hospitals
Children's Healthcare Of Atlanta/Emory University
Emory University/Childrens Healthcare Of Atlanta
Clinical Trials Claudia Morris, MD is currently running
Arginine Therapy
for COVID-19
This study aims to investigate if receiving doses of arginine (a protein in the body) will improve mitochondria function in children with COVID-19. The study will be performed at the Children's Healthcare of Atlanta, Arthur M. Blank Hospital. Patients will be randomized to receive one of three doses of arginine three times a day for five days or at discharge whichever comes first.
Recruiting
1 award
Phase 2
2 criteria
Age-Based Seizure Protocol
for Pediatric Seizures
The Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study is designed to improve how paramedics treat seizures in children on ambulances. Seizures are one of the most common reasons why people call an ambulance for a child, and paramedics typically administer midazolam to stop the seizure. One-third of children with active seizures on ambulances arrive at emergency departments still seizing. Prior research suggests that seizures on ambulances continue due to under-dosing and delayed delivery of medication. Under-dosing happens when calculation errors occur, and delayed medication delivery occurs due to the time required for dose calculation and placement of an intravenous line to give the medication. Seizures stop quickly when standardized medication doses are given as a muscular injection or a nasal spray. This research has primarily been done in adults, and evidence is needed to determine if this is effective and safe in children. PediDOSE optimizes how paramedics choose the midazolam dose by eliminating calculations and making the dose age-based. This study involves changing the seizure treatment protocols for ambulance services in 20 different cities, in a staggered and randomly-assigned manner. One aim of PediDOSE is to determine if using age to select one of four standardized doses of midazolam and giving it as a muscular injection or nasal spray is more effective than the current calculation-based method, as measured by the number of children arriving at emergency departments still seizing. The investigators believe that a standardized seizure protocol with age-based doses is more effective than current practice. Another aim of PediDOSE is to determine if a standardized seizure protocol with age-based doses is just as safe as current practice, since either ongoing seizures or receiving too much midazolam can interfere with breathing. The investigators believe that a standardized seizure protocol with age-based doses is just as safe as current practice, since the seizures may stop faster and these doses are safely used in children in other healthcare settings. If this study demonstrates that standardized, age-based midazolam dosing is equally safe and more effective in comparison to current practice, the potential impact of this study is a shift in the treatment of pediatric seizures that can be easily implemented in ambulance services across the United States and in other parts of the world.
Recruiting
2 awards
Phase 3
3 criteria
More about Claudia Morris, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Claudia Morris, MD has experience with
- Arginine Hydrochloride
- Arginine
- Azithromycin
- Placebo
- Conventional Seizure Protocol
- Standardized Seizure Protocol
Breakdown of trials Claudia Morris, MD has run
Coronavirus
Anosognosia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Claudia Morris, MD specialize in?
Claudia Morris, MD focuses on Sickle Cell Disease and Coronavirus. In particular, much of their work with Sickle Cell Disease has involved Hb-SS positive patients, or patients who are Sβᴼ-thalassemia positive.
Is Claudia Morris, MD currently recruiting for clinical trials?
Yes, Claudia Morris, MD is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Claudia Morris, MD has studied deeply?
Yes, Claudia Morris, MD has studied treatments such as Arginine Hydrochloride, Arginine, Azithromycin.
What is the best way to schedule an appointment with Claudia Morris, MD?
Apply for one of the trials that Claudia Morris, MD is conducting.
What is the office address of Claudia Morris, MD?
The office of Claudia Morris, MD is located at: Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia 30322 United States. This is the address for their practice at the Children's Healthcare of Atlanta, Emory University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.